Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

TitleNeuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.
Publication TypeJournal Article
Year of Publication2005
AuthorsAndersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, von Arnim CAF, Breiderhoff T, Jansen P, Wu X, Bales KR, Cappai R, Masters CL, Gliemann J, Mufson EJ, Hyman BT, Paul SM, Nykjaer A, Willnow TE
JournalProc Natl Acad Sci U S A
Volume102
Issue38
Pagination13461-6
Date Published2005 Sep 20
ISSN0027-8424
KeywordsAlzheimer Disease, Amyloid beta-Protein Precursor, Animals, Brain, CHO Cells, Cricetinae, Cricetulus, Endosomes, Golgi Apparatus, Humans, LDL-Receptor Related Proteins, Membrane Transport Proteins, Mice, Mice, Knockout, Plaque, Amyloid, Protein Processing, Post-Translational, Protein Transport, Receptors, LDL
Abstract

sorLA (Sorting protein-related receptor) is a type-1 membrane protein of unknown function that is expressed in neurons. Its homology to sorting receptors that shuttle between the plasma membrane, endosomes, and the Golgi suggests a related function in neuronal trafficking processes. Because expression of sorLA is reduced in the brain of patients with Alzheimer's disease (AD), we tested involvement of this receptor in intracellular transport and processing of the amyloid precursor protein (APP) to the amyloid beta-peptide (Abeta), the principal component of senile plaques. We demonstrate that sorLA interacts with APP in vitro and in living cells and that both proteins colocalize in endosomal and Golgi compartments. Overexpression of sorLA in neurons causes redistribution of APP to the Golgi and decreased processing to Abeta, whereas ablation of sorLA expression in knockout mice results in increased levels of Abeta in the brain similar to the situation in AD patients. Thus, sorLA acts as a sorting receptor that protects APP from processing into Abeta and thereby reduces the burden of amyloidogenic peptide formation. Consequently, reduced receptor expression in the human brain may increase Abeta production and plaque formation and promote spontaneous AD.

DOI10.1073/pnas.0503689102
Alternate JournalProc. Natl. Acad. Sci. U.S.A.
PubMed ID16174740
PubMed Central IDPMC1224625